pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·Sep 1·1 min read
save

Novocure cyberattack exposes data of over 1,400 U.S. patients and staff

Sep 1, 2026·read at Fierce Biotech ↗Negative

Novocure disclosed a cyberattack in an SEC filing, saying unauthorized access to some information systems was discovered in mid‑August.

The breach exposed internal patient ID numbers for more than 1,400 U.S. patients, but no names; data for fewer than 50 western U.S. patients included additional identifying details. Contact information for healthcare providers and employees was also accessed.

The company emphasized that its medical devices were not compromised and operations remain fully functional. Novocure is investigating the incident and assessing regulatory and legal notification obligations, including informing affected patients.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Novocure hit by cyberattack exposing patient data”

read at Fierce Biotech ↗
345 words · retrieved Sep 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
BOSTON SCIENTIFIC CORP3
drugs
SOR-007gemcitabinepaclitaxelpaclitaxel albumin bound
topics
Medical Device Company8Oncology4

related stories

  • May 10Five Under 5: Top Oncology Videos for the Week of 5/3onclive
  • May 6Dr Pant on the Mechanism of Action of Daraxonrasib in PDAConclive
  • May 5Dr Cohen on Frontline Chemotherapy Selection in Metastatic Pancreatic Canceronclive
  • May 31Ultra-low doses could bring costly cancer treatments to more patients in poorer countriesSTAT
  • May 8Dr Randall on Long-Term Responses and Functional Benefits With Pimicotinib in TGCTonclive